Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination

被引：0
|
作者：
Jorge E. Romaguera
M. Alma Rodriguez
Fredrick B. Hagemeister
Peter McLaughlin
Jose Rodriguez
Alejandro Preti
Anas Younes
Andreas H. Sarris
Fernando Cabanillas
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Lymphoma
来源：
Investigational New Drugs | 1999年 / 17卷
关键词：
relapsed NHL; paclitaxel; MINT chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: Evaluate response, duration of response, and toxicity of paclitaxel in combination with other drugs known to be effective in non-Hodgkin's lymphoma (NHL).
引用
收藏
页码：187 / 192
页数：5
相关论文
共 50 条
  • [31] A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma
    Hill, Brian T.
    Smith, Mitchell R.
    Shelley, Meredeth
    Jagadeesh, Deepa
    Dean, Robert M.
    Pohlman, Brad
    Sweetenham, John W.
    Bolwell, Brian J.
    Smith, Stephen D.
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 690 - 694
  • [32] Dice (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory/relapsed non-Hodgkin's lymphoma (NHL).
    Coleman, M
    Leonard, JP
    Bayer, RL
    Gelfand, RM
    Kaufmann, TP
    BLOOD, 1999, 94 (10) : 523A - 523A
  • [33] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
  • [34] A COMBINATION OF MITOXANTRONE, ETOPOSIDE AND PREDNISONE IN ELDERLY PATIENTS WITH NON-HODGKIN LYMPHOMA
    SALVAGNO, L
    CONTU, A
    BIANCO, A
    ENDRIZZI, L
    SCHINTU, GM
    OLMEO, N
    AVERSA, SML
    CHIARIONSILENI, V
    SORARU, M
    FIORENTINO, MV
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 833 - 837
  • [35] Dexamethasone, cytarabine and oxaliplatin (DHAX) in relapsed or refractory non-Hodgkin's lymphoma patients: Results of an ongoing phase II trial.
    Chau, I
    Cunningham, D
    Hill, M
    Catovsky, D
    BLOOD, 2000, 96 (11) : 140A - 140A
  • [36] Phase II study of oxaliplatin in patients with relapsed or refractory non-Hodgkin's lymphoma: Final results.
    Oki, Y
    McLauhlin, P
    Pro, B
    Hagemeister, FH
    Bleyer, A
    Loyer, E
    Younes, A
    BLOOD, 2004, 104 (11) : 684A - 684A
  • [37] High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma
    Igor Aurer
    Damir Nemet
    Zdravko Mitrović
    Dino Dujmović
    Sandra Bašić-Kinda
    Ivo Radman
    Dubravka Sertić
    Fedor Šantek
    Marko Kralik
    Snježana Dotlić
    Sanja Mazić
    Boris Labar
    Annals of Hematology, 2016, 95 : 1129 - 1136
  • [38] High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma
    Aurer, Igor
    Nemet, Damir
    Mitrovic, Zdravko
    Dujmovic, Dino
    Basic-Kinda, Sandra
    Radman, Ivo
    Sertic, Dubravka
    Santek, Fedor
    Kralik, Marko
    Dotlic, Snjezana
    Mazic, Sanja
    Labar, Boris
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1129 - 1136
  • [39] A PHASE-II TRIAL OF ORAL VP-16 WITH MITOXANTRONE AND IFOSFAMIDE MESNA FOR SALVAGE OF RELAPSED OR REFRACTORY LYMPHOMA
    ROMAGUERA, JE
    RODRIGUEZ, MA
    HAGEMEISTER, FB
    MCLAUGHLIN, P
    SWAN, F
    SARRIS, AH
    YOUNES, A
    HILL, D
    CABANILLAS, F
    BLOOD, 1993, 82 (10) : A576 - A576
  • [40] Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma
    Borchmann, Peter
    Herbrecht, Raoul
    Wilhelm, Martin
    Morschhauser, Franck
    Hess, Georg
    Cernohous, Paul
    Veals, Susan A.
    Singer, Jack W.
    Engert, Andreas
    LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 620 - 628
12345